Suriname Recombinant Coagulation Factors Market (2025-2031) | Challenges, Forecast, Trends, Growth, Competition, Consumer Insights, Segmentation, Revenue, Companies, Analysis, Outlook, Value, Supply, Competitive, Share, Demand, Drivers, Opportunities, Industry, Restraints, Strategy, Segments, Size, Investment Trends, Pricing Analysis, Strategic Insights

Name: Suriname Recombinant Coagulation Factors Market (2025-2031) | Trends, Outlook & Forecast
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Coagulation Factor (Factor VIII, Factor IX, Factor VIIa), By Indication (Hemophilia A, Hemophilia B, Factor VII Deficiency), By End-Use (Healthcare, Pharmaceuticals, Biotechnology) And Competitive Landscape

Product Code: ETC10401641	Publication Date: Apr 2025	Updated Date: Nov 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Bhawna Singh	No. of Pages: 65	No. of Figures: 34	No. of Tables: 19

Suriname Recombinant Coagulation Factors Market: Top 5 Importing Countries and Market Competition (HHI) Analysis

Suriname import of recombinant coagulation factors in 2024 saw a significant concentration of supply from top exporting countries such as Peru, Netherlands, USA, Brazil, and Germany. The Herfindahl-Hirschman Index (HHI) indicating market concentration surged from high to very high in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 2.08%, while there was a notable decline in growth rate from 2023 to 2024 at -8.75%. This suggests a potential shift in market dynamics and the need for a closer examination of the factors influencing this trend.

Suriname Recombinant Coagulation Factors Market: Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

Suriname Recombinant Coagulation Factors Market Outlook
Market Size of Suriname Recombinant Coagulation Factors Market,2024
Forecast of Suriname Recombinant Coagulation Factors Market, 2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Revenues & Volume for the Period 2021-2031
Suriname Recombinant Coagulation Factors Market Trend Evolution
Suriname Recombinant Coagulation Factors Market Drivers and Challenges
Suriname Recombinant Coagulation Factors Price Trends
Suriname Recombinant Coagulation Factors Porter's Five Forces
Suriname Recombinant Coagulation Factors Industry Life Cycle
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Coagulation Factor for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Factor VIII for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Factor IX for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Factor VIIa for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Indication for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Hemophilia A for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Hemophilia B for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Factor VII Deficiency for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By End-Use for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Healthcare for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Pharmaceuticals for the Period 2021-2031
Historical Data and Forecast of Suriname Recombinant Coagulation Factors Market Revenues & Volume By Biotechnology for the Period 2021-2031
Suriname Recombinant Coagulation Factors Import Export Trade Statistics
Market Opportunity Assessment By Coagulation Factor
Market Opportunity Assessment By Indication
Market Opportunity Assessment By End-Use
Suriname Recombinant Coagulation Factors Top Companies Market Share
Suriname Recombinant Coagulation Factors Competitive Benchmarking By Technical and Operational Parameters
Suriname Recombinant Coagulation Factors Company Profiles
Suriname Recombinant Coagulation Factors Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Suriname Recombinant Coagulation Factors Market Overview

3.1 Suriname Country Macro Economic Indicators

3.2 Suriname Recombinant Coagulation Factors Market Revenues & Volume, 2021 & 2031F

3.3 Suriname Recombinant Coagulation Factors Market - Industry Life Cycle

3.4 Suriname Recombinant Coagulation Factors Market - Porter's Five Forces

3.5 Suriname Recombinant Coagulation Factors Market Revenues & Volume Share, By Coagulation Factor, 2021 & 2031F

3.6 Suriname Recombinant Coagulation Factors Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 Suriname Recombinant Coagulation Factors Market Revenues & Volume Share, By End-Use, 2021 & 2031F

4 Suriname Recombinant Coagulation Factors Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of bleeding disorders in Suriname

4.2.2 Growing awareness about recombinant coagulation factors and their benefits

4.2.3 Advancements in biotechnology and healthcare infrastructure in Suriname

4.3 Market Restraints

4.3.1 Limited access to healthcare facilities in remote areas of Suriname

4.3.2 High costs associated with recombinant coagulation factors treatment

4.3.3 Regulatory challenges and approval processes for new products in Suriname

5 Suriname Recombinant Coagulation Factors Market Trends

6 Suriname Recombinant Coagulation Factors Market, By Types

6.1 Suriname Recombinant Coagulation Factors Market, By Coagulation Factor

6.1.1 Overview and Analysis

6.1.2 Suriname Recombinant Coagulation Factors Market Revenues & Volume, By Coagulation Factor, 2021 - 2031F

6.1.3 Suriname Recombinant Coagulation Factors Market Revenues & Volume, By Factor VIII, 2021 - 2031F

6.1.4 Suriname Recombinant Coagulation Factors Market Revenues & Volume, By Factor IX, 2021 - 2031F

6.1.5 Suriname Recombinant Coagulation Factors Market Revenues & Volume, By Factor VIIa, 2021 - 2031F

6.2 Suriname Recombinant Coagulation Factors Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Suriname Recombinant Coagulation Factors Market Revenues & Volume, By Hemophilia A, 2021 - 2031F

6.2.3 Suriname Recombinant Coagulation Factors Market Revenues & Volume, By Hemophilia B, 2021 - 2031F

6.2.4 Suriname Recombinant Coagulation Factors Market Revenues & Volume, By Factor VII Deficiency, 2021 - 2031F

6.3 Suriname Recombinant Coagulation Factors Market, By End-Use

6.3.1 Overview and Analysis

6.3.2 Suriname Recombinant Coagulation Factors Market Revenues & Volume, By Healthcare, 2021 - 2031F

6.3.3 Suriname Recombinant Coagulation Factors Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F

6.3.4 Suriname Recombinant Coagulation Factors Market Revenues & Volume, By Biotechnology, 2021 - 2031F

7 Suriname Recombinant Coagulation Factors Market Import-Export Trade Statistics

7.1 Suriname Recombinant Coagulation Factors Market Export to Major Countries

7.2 Suriname Recombinant Coagulation Factors Market Imports from Major Countries

8 Suriname Recombinant Coagulation Factors Market Key Performance Indicators

8.1 Patient adherence rates to recombinant coagulation factor therapy

8.2 Number of healthcare professionals trained in the use of recombinant coagulation factors

8.3 Rate of adoption of recombinant coagulation factors as a standard of care in Suriname

9 Suriname Recombinant Coagulation Factors Market - Opportunity Assessment

9.1 Suriname Recombinant Coagulation Factors Market Opportunity Assessment, By Coagulation Factor, 2021 & 2031F

9.2 Suriname Recombinant Coagulation Factors Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 Suriname Recombinant Coagulation Factors Market Opportunity Assessment, By End-Use, 2021 & 2031F

10 Suriname Recombinant Coagulation Factors Market - Competitive Landscape

10.1 Suriname Recombinant Coagulation Factors Market Revenue Share, By Companies, 2024

10.2 Suriname Recombinant Coagulation Factors Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Recombinant Coagulation Factors Market

Cote D'Ivoire Recombinant Coagulation Factors Market

Costa Rica Recombinant Coagulation Factors Market

Croatia Recombinant Coagulation Factors Market

Cuba Recombinant Coagulation Factors Market

Cyprus Recombinant Coagulation Factors Market

Europe Recombinant Coagulation Factors Market

Global Recombinant Coagulation Factors Market

Middle East Recombinant Coagulation Factors Market

North America Recombinant Coagulation Factors Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here